switching between glp-1 agonists ada Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance #4 NN Clinical Use
Description
Summary of included studies regarding the adverse psychiatric outcomes associated with GLP-1-RAs)
GLP-1 Effects: Activating the GLP-1 receptor delays stomach emptying, supported by research in both animals and humans
62 Different ligands lead to different interaction patterns with the receptor, generating various effects
Constipation rates are comparable to semaglutide, but tirzepatide users often report more intense initial gastrointestinal symptoms that tend to resolve more quickly as the medication takes effect
Plummer CW, Clements MJ, Chen H, Rajagopalan M, Josien H, Hagmann WK, et al
